P (continued)
- PVDF / sirolimus topical
- pyrazine diazohydroxide
- pyrazofurin
- pyrazoloacridine
- pyridoxine hydrochloride
- pyrimethamine
- pyroxamide
- pyruvate kinase inhibitor TLN-232
X
- xaliproden hydrochloride
- Xanax
- Xanthotoxin
- Xcytrin
- Xeloda
- XELOX regimen
- xenogeneic tyrosinase DNA vaccine
- Xerecept
- Xifaxan
- Xinlay
- XL184
- XL647
- XL820
- XL844
- Xolegel
- Xylocaine
- Xylocitin
X (continued)
- Xyotax
Y
- Y-90 OctreoTher
- YM598
- yoshi-864
- yttrium Y 90 anti-CD19 monoclonal antibody BU12
- yttrium Y 90 anti-CD45 monoclonal antibody AHN-12
- yttrium Y 90 anti-CD66 monoclonal antibody BW 250 / 183
- yttrium Y 90 anti-CEA monoclonal antibody cT84.66
- yttrium Y 90 daclizumab
- yttrium Y 90 DOTA anti-CEA monoclonal antibody M5A
- yttrium Y 90 DOTA monoclonal antibody HuAFP31
- yttrium Y 90 DOTA monoclonal antibody HuPAM4
- yttrium Y 90 epratuzumab
- yttrium Y 90 glass microspheres
- yttrium Y 90 ibritumomab tiuxetan
- yttrium Y 90 monoclonal antibody B3
- yttrium Y 90 monoclonal antibody BrE-3
- yttrium Y 90 monoclonal antibody Hu3S193
- yttrium Y 90 monoclonal antibody MN-14
- yttrium Y 90 resin microspheres
- yttrium Y 90-DOTA-chimeric monoclonal antibody cG250
- yttrium Y 90-edotreotide
- yttrium-90 polycarbonate brachytherapy plaque
Z
- Z-360
- zalcitabine